Acne therapy with topical benzoyl peroxide, antibiotics and azelaic acid;Topische therapie mit benzoylperoxid, antibiotika und azelainsäure bei der akne

JDDG - Journal of the German Society of Dermatology

Volumn 4, Issue 4, 2006, Pages 293-300

  Worret, Wolf Ingo ^a   Fluhr, Joachim W ^b  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPALENE; ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; AZELAIC ACID; BENZOYL PEROXIDE; CHLORAMPHENICOL; CLINDAMYCIN; ERYTHROMYCIN; ESSENTIAL OIL; MICONAZOLE; MINOCYCLINE; NADIFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RETINOIC ACID; RETINOID; SULFONATED SHALE OIL; TETRACYCLINE; UNCLASSIFIED DRUG; ZINC; DERMATOLOGICAL AGENT; DICARBOXYLIC ACID;

ACNE; ANTIBIOTIC RESISTANCE; ANTIINFLAMMATORY ACTIVITY; APLASTIC ANEMIA; APPLICATION SITE BURNING; APPLICATION SITE DISCOLORATION; APPLICATION SITE DRYNESS; APPLICATION SITE ERYTHEMA; APPLICATION SITE IRRITATION; APPLICATION SITE PRURITUS; BLOOD TOXICITY; BONE MARROW DISEASE; CLINICAL TRIAL; CONCENTRATION RESPONSE; DESQUAMATION; DIARRHEA; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG MECHANISM; DRUG PENETRATION; DRUG SAFETY; FOLLICULITIS; HUMAN; INFLAMMATION; LACTATION; LONG TERM CARE; NAUSEA; OXIDATION REDUCTION POTENTIAL; PHOTOTOXICITY; PREGNANCY; PSEUDOMEMBRANOUS COLITIS; REVIEW; SKIN ALLERGY; SKIN REDNESS; SKIN SENSITIZATION; SKIN TIGHTNESS; TREATMENT DURATION; TREATMENT INDICATION; VOMITING; ACNE VULGARIS; CLINICAL PRACTICE; GERMANY; PRACTICE GUIDELINE; TOPICAL DRUG ADMINISTRATION;

ACNE VULGARIS; ADMINISTRATION, TOPICAL; ANTI-BACTERIAL AGENTS; BENZOYL PEROXIDE; DERMATOLOGIC AGENTS; DICARBOXYLIC ACIDS; GERMANY; HUMANS; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES;

EID: 33646845447     PISSN: 16100379     EISSN: 16100387     Source Type: Journal    
DOI: 10.1111/j.1610-0387.2006.05931.x     Document Type: Review

References (49)

1. Hegemann L., Toso SM, Kitay K, Webster GF. Anti-inflammatory actions of benzoyl peroxide: effects on the generation of reactive oxygen species by leucocytes and the activity of protein kinase C and calmodulin. Br J Dermatol 1994; 130: 569-575.
2. Thiele JJ. Oxidative targets in the stratum corneum. A new basis for antioxidative strategies. Skin Pharmacol Appl Skin Physiol 2001; 14 Suppl 1: 87-91.
3. Chalker DK., Shalita A, Smith JG Jr, Swann RW. A double-blind study of the effectiveness of a 3 % erythromycin and 5 % benzoyl peroxide combination in the treatment of acne vulgaris. J Am Acad Dermatol 1983; 9: 933-936.
4. Fyrand O, Jakobsen HB. Water-based versus alcohol-based benzoyl peroxide preparations in the treatment of acne vulgaris. Dermatologica 1986; 172: 263-267.
5. Lookingbill DP, Chalker DK, Lindholm JS, Katz HI, Kemper SE, Huerter CJ, Swinehart JM, Schelling DJ, Klanda HC. Treatment of acne with a combination clindamycin/benzoyl peroxide gel compared with clindamycin gel, benzoyl peroxide gel and vehicle gel: combined results of two double-blind investigations. J Am Acad Dermatol 1997; 37: 590-595.
6. Smith EB, Padilla RS, McCabe JM, Becker LE. Benzoyl peroxide lotion (20 percent) in acne. Cutis 1980; 25: 90-92.
7. Sackett DL, Straus SE, Richardson WS, Rosenberg W, Haynes RB. Evidence-based medicine. How to practice and teach EBM. 2001; Churchill Livingstone: London: 169-182.
8. Mills OH Jr, Kligman AM, Pochi P, Comite H. Comparing 2.5 %, 5 %, and 10 % benzoyl peroxide on inflammatory acne vulgaris. Int J Dermatol 1986; 25: 664-667.
9. Cunliffe WJ, Burke B. Benzoyl peroxide: lack of sensitization. Acta Derm Venereol 1982; 62: 458-459.
10. Jeanmougin M, Pedreiro J, Bouchet J, Civatte J. [Phototoxic activity of 5 % benzoyl peroxide in man. Use of a new methodology]. Dermatologica 1983; 167: 19-23.
11. Fanta D, Scholz N. [Miconazole-benzoyl peroxide: a new combination for extending the topical therapy of acne]. Z Hautkr 1984; 59: 873-881.
12. Lassus A. Local treatment of acne. A clinical study and evaluation of the effect of different concentrations of benzoyl peroxide gel. Curr Med Res Opin 1981; 7: 370-373.
13. Jones EL, Crumley AF. Topical erythromycin vs blank vehicle in a multiclinic acne study. Arch Dermatol 1981; 117: 551-553.
14. Perez Lopez M, Moragas Vinas JM. Nueva sal de eritromicina (A-137 o laurilsulfato de eritromicina) en el tratamiento topico del acne. Med Cutan Ibero Lat Am 1982; 10: 151-158.
15. Prince RA, Busch DA, Hepler CD, Feldick HG. Clinical trial of topical erythromycin in inflammatory acne. Drug Intell Clin Pharm 1981; 15: 372-376.
16. Thiboutot D. Acne: 1991-2001. J Am Acad Dermatol 2002; 47: 109-117.
17. Toyoda M, Morohashi M. An overview of topical antibiotics for acne treatment. Dermatology 1998; 196: 130-134.
18. Eady AE, Cove JH, Layton AM. Is antibiotic resistance in cutaneous propionibacteria clinically relevant?: implications of resistance for acne patients and prescribes. Am J Clin Dermatol 2003; 4: 813-831.
19. Ross JI, Snelling AM, Carnegie E, Coates P, Cunliffe WJ, Bettoli V, Tosti G, Katsambas A, Galvan Perez Del Pulgar JI, Rollman O, Torok L, Eady EA, Cove JH. Antibiotic-resistant acne: lessons from Europe. Br J Dermatol 2003; 148: 467-478.
20. Coates P, Vyakrnam S, Eady EA, Jones CE, Cove JH, Cunliffe WJ. Prevalence of antibiotic-resistant propionibacteria on the skin of acne patients: 10-year surveillance data and snapshot distribution study. Br J Dermatol 2002; 146: 840-848.
21. Fluhr JW, Gloor M, Dietz P, Hoffler U. In Vitro activity of 6 antimicrobials against propionibacteria isolates from untreated acne papulopustulosa. Zentralbl Bakteriol 1999; 289: 53-61.
22. Ross JI, Eady EA, Cove JH, Ratyal AH, Cunliffe WJ. Resistance to erythromycin and clindamycin in cutaneous propionibacteria is associated with mutations in 23S rRNA. Dermatology 1998; 196: 69-70.
23. Habbema L, Koopmans B, Menke HE, Doornweerd S, De Boulle K. A 4 % erydiromycin and zinc combination (Zineryt) versus 2 % erythromycin (Eryderm) in acne vulgaris: a randomized, double-blind comparative study. Br J Dermatol 1989; 121: 497-502.
24. Fluhr JW, Bosch B, Gloor M, Hoffler U. In-vitro and in-vivo efficacy of zinc acetate against propionibacteria alone and in combination with erythromycin. Zentralbl Bakteriol 1999; 289: 445-456.
25. Saihan EM, Burton JL, Meyrick G, Speller DC, Thornton E, Chestney V. The effect of a topical antibiotic preparation in acne vulgaris - a controlled clinical and laboratory study. Br J Clin Pract 1981; 35: 106-109.
26. Fraser NB, Main RA, Stewart TW, Thornton EJ. Treatment of acne vulgaris comparing two similar lotion formulations, one with ('Actinac') and one without chloramphenicol. Curr Med Res Opin 1980; 6: 461-465.
27. Fluhr JW, Gloor M, Merkel W, Warnecke J, Hoffler U, Lehmacher W, Glutsch J. Antibacterial and sebosuppressive efficacy of a combination of chloramphenicol and pale sulfonated shale oil. Multicentre, randomized, vehicle-controlled, double-blind study on 91 acne patients with acne papulopustulosa (Plewig and Kligman's grade II-III). Arzneimittelforschung 1998; 48: 188-196.
28. Cunliffe WJ, Burke B, Dodman B. Chloramphenicol and benzoyl peroxide in acne. A double-blind clinical study. Practitioner 1980; 224: 952-954.
29. Forck G. [Incidence and significance of chloramphenicol hypersensitivities with respect to different ways of sensibilization]. Dtsch Med Wochenschr 1971; 96: 161-165.
30. Goh CL. Contact sensitivity to topical antimicrobials. (II). Sensitizing potentials of some topical antimicrobials. Contact Dermatitis 1989; 21: 166-171.
31. Warnecke J, Fehrs W. [Local treatment with chloramphenicol]. Hautarzt 1998; 49: 55.
32. Kurokawa L, Akamatsu H, Nishijima S, Asada Y, Kawabata S. Clinical and bacteriologic evaluation of OPC-7251 in patients with acne: a double-blind group comparison study versus cream base. J Am Acad Dermatol 1991; 25: 674-681.
33. Vogt K, Hermann J, Blume U, Gollnick H, Hahn H, Haustein UF, Orfanos CE. Comparative activity of the topical quinolone OPC-7251 against bacteria associated with acne vulgaris. Eur J Clin Microbiol Infect Dis 1992; 11: 943-945.
34. Vogt K, Hahn H, Hermann J, Haustein UF, Blume U, Gollnick H, Orfanos CE. Antimicrobial evaluation of nadifloxacin (OPC-7251), a new topical quinolone, in acne vulgaris. Drugs 1995; 49: 266-268.
35. Becker LE, Bergstresser PR, Whiting, DA, Clendenning WE, Dobson RL, Jordan WP, Abell E, LeZotte LA, Pochi PE, Shupack JL, Sigafoes RB, Stoughton RB, Voorhees JJ. Topical clindamycin therapy for acne vulgaris. A cooperative clinical study. Arch Dermatol 1981; 117: 482-485.
36. Christian GL, Krueger GG. Clindamycin vs placebo as adjunctive therapy in moderately severe acne. Arch Dermatol 1975; 111: 997-1000.
37. Leyden JJ, Berger RS, Dunlap FE, Ellis CN, Connolly MA, Levy SF. Comparison of the efficacy and safety of a combination topical gel formulation of benzoyl peroxide and clindamycin with benzoyl peroxide, clindamycin and vehicle gel in the treatments of acne vulgaris. Am J Clin Dermatol 2001; 2: 33-39.
38. Milstone EB, McDonald AJ, Scholhamer CF Jr. Pseudomembranous colitis after topical application of clindamycin. Arch Dermatol 1981; 117: 154-155.
39. Parry MF, Rha CK. Pseudomembranous colitis caused by topical clindamycin phosphate. Arch Dermatol 1986; 122: 583-584.
40. Tschen EH, Katz HI, Jones TM, Monroe EW, Connolly MA, Levy SE. A combination benzoyl peroxide and clindamycin topical gel compared with benzoyl peroxide, clindamycin phosphate, and vehicle in the treatment of acne vulgaris. Cutis 2001; 67: 165-169.
41. Smith JG Jr, Chalker DK, Wehr RF. The effectiveness of topical and oral tetracycline for acne. South Med J 1976; 69: 695-697.
42. Anderson RL, Cook CH, Smith DE. The effect of oral and topical tetracycline on acne severity and on surface lipid composition. J Invest Dermatol 1976; 66: 172-177.
43. Blaney DJ, Cook CH. Topical use of tetracycline in the treatment of acne: a double-blind study comparing topical and oral tetracycline therapy and placebo. Arch Dermatol 1976; 112: 971-973.
44. Panzer JD, Poche W, Meek TJ, Derbes VJ, Atkinson W. Acne treatment: a comparative efficacy trial of clindamycin and tetracycline. Cutis 1977; 19: 109-111.
45. Cunliffe WJ, Gollnick HPM, Orfanos CE. Akne. Hippokrates Verlag Stuttgart, 1993.
46. Giannotti B. [National and international clinical experiences with azelaic acid cream in the treatment of comedo acne]. G Ital Dermatol Venereol 1989; 124: 471-417.
47. Graupe K, Cunliffe W, Gollnick HP, Zaumseil RP. Efficacy and safety of topical azelaic acid (20 percent cream): an overview of results from European clinical trials and experimental reports. Cutis 1996; 57: 20-35.
48. Gollnick HP, Graupe K, Zaumseil RP. Comparison of combined azelaic acid cream plus oral minocycline with oral isotretinoin in severe acne. Eur J Dermatol 2001; 11: 538-544.
49. Gollnick HP, Graupe K, Zaumseil RP. [Azelaic acid 15 % gel in the treatment of acne vulgaris. Combined results of two double-blind clinical comparative studies]. J Dtsch Dermatol Ges 2004; 2: 841-847.